Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News JW Therapeutics says China pharma deals remain insulated from Beijing’s sensitive technology scrutiny JW Therapeutics says China pharma deals remain open despite Beijing tech scrutiny. See why biotech licensing still matters. byPallavi MadhirajuMay 28, 2026